Chief Business Officer
Christina Isacson is our Chief Business Officer and is responsible for Magenta’s business development, alliance management, portfolio management, and commercial strategy. Christina joined Magenta in 2016 from Third Rock Ventures which she joined as a principal in 2013 and was a key member of the founding team for Magenta. While at Third Rock Ventures, she was part of the founding management team for Decibel Therapeutics and Interim Head of Business Development for Edimer Pharmaceuticals. Prior to joining Third Rock Ventures, Christina served as a senior member of the corporate development team at Ironwood Pharmaceuticals, where she led the business and commercial roles on several drug development teams and contributed to the growth of the pipeline through the establishment and management of the company’s in-licensing efforts. Prior to Ironwood, she formed several early-stage companies in collaboration with venture groups in Boston and Seattle.
Christina earned a doctorate in neuroscience from Tufts University School of Medicine and an undergraduate degree in biology from McGill University.